New Molecular Entities to Treat Substance Use Disorders (R01)

Archived

National Institutes of Health

Description

The National Institute on Drug Abuse (NIDA) is soliciting grant (R01) applications for preclinical research projects that can be conducted with accelerated pace from the drug discovery stage to the early development stage, with the ultimate goal of identifying new molecular entities (NME) as candidate compounds and moving them closer to gaining FDA approval of safe and efficacious medications for the treatment of substance use disorders (SUDs).

Who can apply

  • State governments
  • County governments
  • City or township governments
  • Special district governments
  • Independent school districts
  • Public and State controlled institutions of higher education
  • Native American tribal governments (Federally recognized)
  • Public housing authorities / Indian housing authorities
  • Native American tribal organizations (other than Federally recognized)
  • Nonprofits with 501(c)(3) status (other than higher education)
  • Nonprofits without 501(c)(3) status (other than higher education)
  • Private institutions of higher education
  • For-profit organizations other than small businesses
  • Small businesses
  • Others

Contact

NIH OER Webmaster<br/>FBOWebmaster@OD.NIH.GOV<br/>
FBOWebmaster@OD.NIH.GOV

Key dates & funding
  • PostedDec 22, 2010
  • ClosesMar 17, 2011
  • Program funding$2,000,000
  • CFDA93.279
Categories

Pro insight

Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.

Unlock with Pro